Diffusion Pharmaceuticals (DFFN) News Today → Truth about Trump you’ve never heard (From Porter & Company) (Ad) Free DFFN Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative April 18, 2024 | bbc.co.ukComparing diffusion, osmosis and active transportFebruary 10, 2024 | thestreet.comDiffusion Pharmaceuticals Inc.February 8, 2024 | bizjournals.comVertex co-founder Josh Boger joins Boston biotech working on dementia drugDecember 22, 2023 | venturebeat.comStable Video Diffusion is now available through Stability AI APIAugust 16, 2023 | finanznachrichten.deDiffusion Pharmaceuticals Inc.: Diffusion Pharmaceuticals Stockholders Approve Merger with EIP PharmaAugust 16, 2023 | finanznachrichten.deDiffusion Pharmaceuticals Inc.: Diffusion Pharmaceuticals Stockholders Approve Merger with EIP Pharma / Announces 1-for-1.5 Reverse Stock SplitAugust 15, 2023 | finance.yahoo.comDiffusion Pharmaceuticals Stockholders Approve Merger with EIP PharmaJuly 24, 2023 | finance.yahoo.comDiffusion Pharmaceuticals Inc. (DFFN) stock forecast and price targetMay 23, 2023 | benzinga.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FOCS, RADI, BGRY, DFFNMarch 31, 2023 | marketwatch.comSHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Diffusion Pharmaceuticals Inc. MergerMarch 30, 2023 | technews.tmcnet.comDFFN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Diffusion Pharmaceuticals Inc. Is Fair to ShareholdersMarch 30, 2023 | msn.comDiffusion to merge with EIP Pharma in all-stock dealMarch 30, 2023 | finance.yahoo.comEIP Pharma and Diffusion Pharmaceuticals Announce Merger Agreement to Create Leading CNS-focused Company Treating Neurodegenerative DiseasesDecember 16, 2022 | markets.businessinsider.comDiffusion's Shareholder LifeSci Supports Company's Strategic Review Process And Director NomineesDecember 16, 2022 | finance.yahoo.comDiffusion Pharmaceuticals Announces Agreement with LifeSci Special OpportunitiesDecember 5, 2022 | finance.yahoo.comDiffusion Pharmaceuticals Sends Letter to Stockholders Highlighting Strength of Board Leadership and Positive Progress in Strategic Review, Cautioning Stockholders Regarding LifeSci’s History of Stockholder Value Destruction and Self-DealingDecember 1, 2022 | finance.yahoo.comDFFN: Strategic Review Underway; Planning to Initiate Phase 2 GBM Trial in 1Q23…November 15, 2022 | finance.yahoo.comDiffusion Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business UpdateNovember 14, 2022 | finance.yahoo.comDiffusion Pharmaceuticals Sees Significant Progress in its Strategic Review ProcessOctober 15, 2022 | forbes.comDiffusion PharmaceuticalsSeptember 29, 2022 | finance.yahoo.comDiffusion Pharmaceuticals Inc. (DFFN)August 17, 2022 | seekingalpha.comDiffusion raised to Buy at H.C. Wainwright after Q2 update on lead assetAugust 17, 2022 | finance.yahoo.comDFFN: Phase 2 GBM Trial to Initiate 2H22…August 11, 2022 | finance.yahoo.comDiffusion Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business UpdateJuly 26, 2022 | finance.yahoo.comDiffusion Pharmaceuticals to Initiate Phase 2 Trial in Patients with Glioblastoma Multiforme Incorporating Innovative Imaging Methodology to Evaluate Tumor OxygenationJune 23, 2022 | finance.yahoo.comDiffusion Pharmaceuticals Announces Positive Effects in Altitude TrialMay 20, 2022 | finance.yahoo.comDFFN: Data from Altitude Trial Expected in June 2022…May 18, 2022 | finance.yahoo.comDiffusion Pharmaceuticals Announces Appointment of Raven Jaeger, M.S., as Chief Regulatory OfficerMay 17, 2022 | finance.yahoo.comDiffusion Pharmaceuticals to Present at H.C. Wainwright Global Investment ConferenceMay 14, 2022 | seekingalpha.comDiffusion Pharmaceuticals GAAP EPS of -$2.22May 13, 2022 | finance.yahoo.comDiffusion Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business UpdateMay 4, 2022 | finance.yahoo.comDiffusion Pharmaceuticals Regains Compliance With Nasdaq Listing RequirementsApril 19, 2022 | markets.businessinsider.com5 Stocks Halted In Tuesday's SessionApril 19, 2022 | nasdaq.comDiffusion Pharma Falls 18% After Announcing Reverse Stock SplitApril 19, 2022 | marketbeat.comTrading was temporarily halted for "DFFN" at 09:04 AM with a stated reason of "LULD pause."April 19, 2022 | finanznachrichten.deDiffusion Pharmaceuticals Inc.: Diffusion Pharmaceuticals Announces 1-for-50 Reverse Stock Split as Part of Nasdaq Compliance PlanApril 18, 2022 | uk.investing.comWhy Diffusion Pharmaceuticals Shares Are FallingApril 18, 2022 | seekingalpha.comDiffusion Pharma crashes after announcing reverse stock splitApril 18, 2022 | finance.yahoo.comDiffusion Pharmaceuticals' 50-For-1 Stock Split Will Go Into Effect TomorrowApril 18, 2022 | finance.yahoo.comDiffusion Pharmaceuticals Announces 1-for-50 Reverse Stock Split as Part of Nasdaq Compliance PlanApril 11, 2022 | finance.yahoo.comDiffusion Pharmaceuticals Completes Dosing in Altitude TrialApril 8, 2022 | finance.yahoo.comDiffusion Pharmaceuticals Announces New Date for Previously Announced Special Meeting of StockholdersApril 8, 2022 | finance.yahoo.comDiffusion Pharmaceuticals Announces New Date for Previously Announced Special Meeting of StockholdersMarch 23, 2022 | finance.yahoo.comDFFN: Additional Tissue Oxygenation Trial Results Expected Mid-2022…March 21, 2022 | finance.yahoo.comDiffusion Pharmaceuticals Reports 2021 Financial Results and Provides Business UpdateMarch 9, 2022 | finance.yahoo.comWe're Keeping An Eye On Diffusion Pharmaceuticals' (NASDAQ:DFFN) Cash Burn RateFebruary 24, 2022 | finance.yahoo.comDiffusion Pharmaceuticals Expands its Scientific Advisory Board with the Addition of Leading Radiation and Medical Oncology ExpertsDecember 20, 2021 | finance.yahoo.comDiffusion Pharmaceuticals to Present at H.C. Wainwright BioConnect, Participate in Biotech Showcase and Bio Partnering at JPM during “J.P. Morgan Week 2022”December 16, 2021 | finance.yahoo.comDiffusion Pharmaceuticals Doses First Patients in ILD-DLCO TrialDecember 1, 2021 | finance.yahoo.comDiffusion Pharmaceuticals Announces Issuance of U.S. Patent 11,185,523 Get Diffusion Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for DFFN and its competitors with MarketBeat's FREE daily newsletter. Email Address The 1,000X Crypto Playbook (Ad)Chris Rowe has created a “Crypto Playbook” that anyone can follow… potentially turning small investments into pers #1 Crypto for 2024, completely FREE. DFFN Media Mentions By Week DFFN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DFFN News Sentiment▼0.000.44▲Average Medical News Sentiment DFFN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DFFN Articles This Week▼00▲DFFN Articles Average Week Get Diffusion Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for DFFN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: CMMB News Today ATHE News Today ADXN News Today UPC News Today CANF News Today NCNA News Today MTEM News Today VCNX News Today RNAZ News Today ASLN News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:DFFN) was last updated on 5/23/2024 by MarketBeat.com Staff From Our PartnersBitcoin’s Biggest Year YetParadigm PressDividend-like income from non-dividend stocksUnstoppable ProsperityMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceThis could mean the end of the U.S dollar…Colonial MetalsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersGold Set to EXPLODE!Gold Safe Exchange[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaWrite this ticker symbol down…StocksToTrade Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Diffusion Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.